26 May 2013
Keywords: Novo Nordisk, Financial results, Nine months 2012
Article | 31 October 2012
Danish insulin giant Novo Nordisk (NOV: N) today reported financial results for the first nine months of 2012 with 18% growth in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.